Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial

被引：0

作者：

Elkins, Jacob ^{[1
]}

Elkind, Mitchell ^{[2
]}

Veltkamp, Roland ^{[3
]}

Montaner, Joan ^{[8
]}

Johnston, S. ^{[6
]}

Singhal, Aneesh ^{[4
]}

Becker, Kyra ^{[7
]}

Lansberg, Maarten ^{[5
]}

Chang, Ih ^{[1
]}

Tang, Weihua ^{[1
]}

Gheuens, Sarah ^{[1
]}

Mehta, Lahar ^{[1
]}

机构：

[1] Biogen, Cambridge, MA USA

[2] Columbia Univ, New York, NY USA

[3] Imperial Coll London, London, England

[4] Massachusetts Gen Hosp, Boston, MA 02114 USA

[5] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[6] Univ Texas, Auston, TX USA

[7] Univ Washington, Seattle, WA 98195 USA

[8] Vall dHebron Res Inst, Barcelona, Spain

来源：

NEUROLOGY | 2016年 / 86卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S7.005

引用

页数：2

共 50 条

[1] Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial
Elkins, Jacob
Elkind, Mitchell
Veltkamp, Roland
Montaner, Joan
Johnston, S.
Singhal, Aneesh
Becker, Kyra
Lansberg, Maarten
Chang, Ih
Tang, Weihua
Gheuens, Sarah
Mehta, Lahar
NEUROLOGY, 2016, 86
[2] Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial
Elkins, Jacob
Elkind, Mitchell
Veltkamp, Roland
Montanera, Joan
Johnston, S.
Singhal, Aneesh
Becker, Kyra
Lansberg, Maarten
Chang, Ih
Tang, Weihua
Gheuens, Sarah
Mehta, Lahar
NEUROLOGY, 2016, 86
[3] Natalizumab Versus Placebo in Patients with Acute Ischemic Stroke (AIS): Results from ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial
Elkins, Jacob
Elkind, Mitchell
Veltkamp, Roland
Montaner, Joan
Johnston, S.
Singhal, Aneesh
Becker, Kyra
Lansberg, Maarten
Chang, Ih
Tang, Weihua
Gheuens, Sarah
Mehta, Lahar
NEUROLOGY, 2016, 86
[4] Natalizumab Versus Placebo in Patients with Acute Ischemic is Stroke (AIS): Results fro ACTION, a Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Clinical Trial
Elkins, Jacob
Elkind, Mitchell
Veltkamp, Roland
Montaner, Joan
Johnston, S.
Singhal, Aneesh
Becker, Kyra
Lansberg, Maarten
Chang, Ih
Tang, Weihua
Gheuens, Sarah
Mehta, Lahar
NEUROLOGY, 2016, 86
[5] Cerebrolysin in Patients With Acute Ischemic Stroke in Asia Results of a Double-Blind, Placebo-Controlled Randomized Trial
Heiss, Wolf-Dieter
Brainin, Michael
Bornstein, Natan M.
Tuomilehto, Jaakko
Hong, Zhen
STROKE, 2012, 43 (03) : 630 - 636
[6] Natalizumab versus placebo in patients with secondary progressive multiple sclerosis (SPMS): Results from ASCEND, a multicenter, double-blind, placebo-controlled, randomized phase 3 clinical trial
Steiner, Deborah
Arnold, Douglas
Freedman, Mark
Goldman, Myla
Hartung, Hans-Peter
Havrdova, Eva
Jeffery, Douglas
Kapoor, Raj
Miller, Aaron
Sellebjerg, Finn
Amarante, Diogo
Cadavid, Diego
Yu, Bei
Forrestal, Fiona
Liu, Kezhen
NEUROLOGY, 2016, 87 (02) : E22 - E22
[7] Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial
Elkins, Jacob
Veltkamp, Roland
Montaner, Joan
Johnston, S. Claiborne
Singhal, Aneesh B.
Becker, Kyra
Lansberg, Maarten G.
Tang, Weihua
Chang, Ih
Muralidharan, Kumar
Gheuens, Sarah
Mehta, Lahar
Elkind, Mitchell S. V.
LANCET NEUROLOGY, 2017, 16 (03): : 217 - 226
[8] Ebselen in acute ischemic stroke - A placebo-controlled, double-blind clinical trial
Yamaguchi, T
Sano, K
Takakura, K
Saito, I
Shinohara, Y
Asano, T
Yasuhara, H
STROKE, 1998, 29 (01) : 12 - 17
[9] Natalizumab in acute ischemic stroke (ACTION II) A randomized, placebo-controlled trial
Elkind, Mitchell S. V.
Veltkamp, Roland
Montaner, Joan
Johnston, S. Claiborne
Singhal, Aneesh B.
Becker, Kyra
Lansberg, Maarten G.
Tang, Weihua
Kasliwal, Rachna
Elkins, Jacob
NEUROLOGY, 2020, 95 (08) : E1091 - E1104
[10] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NIMODIPINE IN ACUTE ISCHEMIC HEMISPHERIC STROKE
KASTE, M
FOGELHOLM, R
ERILA, T
PALOMAKI, H
MURROS, K
RISSANEN, A
SARNA, S
STROKE, 1994, 25 (07) : 1348 - 1353

← 1 2 3 4 5 →